Advances in the diagnosis and treatment of the hirsute patient

E. S. Knochenhauer, R. Azziz

Research output: Contribution to journalReview article

27 Citations (Scopus)

Abstract

Most patients with hirsutism demonstrate hyperandrogenemia, which may be caused by polycystic ovary syndrome, nonclassic congenital adrenal hyperplasia, insulin resistance and, occasionally, neoplasms. In this review, current methods of diagnosis and recent advances in the medical treatment of hirsutism and hyperandrogenemia are discussed, including the use and gonadotropin-releasing hormone analogs, flutamide, spironolactone, finasteride, and ketoconazole.

Original languageEnglish (US)
Pages (from-to)344-350
Number of pages7
JournalCurrent Opinion in Obstetrics and Gynecology
Volume7
Issue number5
StatePublished - Jan 1 1995

Fingerprint

Hirsutism
Finasteride
Flutamide
Congenital Adrenal Hyperplasia
Spironolactone
Ketoconazole
Polycystic Ovary Syndrome
Gonadotropin-Releasing Hormone
Insulin Resistance
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Advances in the diagnosis and treatment of the hirsute patient. / Knochenhauer, E. S.; Azziz, R.

In: Current Opinion in Obstetrics and Gynecology, Vol. 7, No. 5, 01.01.1995, p. 344-350.

Research output: Contribution to journalReview article

Knochenhauer, E. S. ; Azziz, R. / Advances in the diagnosis and treatment of the hirsute patient. In: Current Opinion in Obstetrics and Gynecology. 1995 ; Vol. 7, No. 5. pp. 344-350.
@article{4418236275ac42b59f0198c11c49ae65,
title = "Advances in the diagnosis and treatment of the hirsute patient",
abstract = "Most patients with hirsutism demonstrate hyperandrogenemia, which may be caused by polycystic ovary syndrome, nonclassic congenital adrenal hyperplasia, insulin resistance and, occasionally, neoplasms. In this review, current methods of diagnosis and recent advances in the medical treatment of hirsutism and hyperandrogenemia are discussed, including the use and gonadotropin-releasing hormone analogs, flutamide, spironolactone, finasteride, and ketoconazole.",
author = "Knochenhauer, {E. S.} and R. Azziz",
year = "1995",
month = "1",
day = "1",
language = "English (US)",
volume = "7",
pages = "344--350",
journal = "Current Opinion in Obstetrics and Gynecology",
issn = "1040-872X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Advances in the diagnosis and treatment of the hirsute patient

AU - Knochenhauer, E. S.

AU - Azziz, R.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Most patients with hirsutism demonstrate hyperandrogenemia, which may be caused by polycystic ovary syndrome, nonclassic congenital adrenal hyperplasia, insulin resistance and, occasionally, neoplasms. In this review, current methods of diagnosis and recent advances in the medical treatment of hirsutism and hyperandrogenemia are discussed, including the use and gonadotropin-releasing hormone analogs, flutamide, spironolactone, finasteride, and ketoconazole.

AB - Most patients with hirsutism demonstrate hyperandrogenemia, which may be caused by polycystic ovary syndrome, nonclassic congenital adrenal hyperplasia, insulin resistance and, occasionally, neoplasms. In this review, current methods of diagnosis and recent advances in the medical treatment of hirsutism and hyperandrogenemia are discussed, including the use and gonadotropin-releasing hormone analogs, flutamide, spironolactone, finasteride, and ketoconazole.

UR - http://www.scopus.com/inward/record.url?scp=0028803447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028803447&partnerID=8YFLogxK

M3 - Review article

VL - 7

SP - 344

EP - 350

JO - Current Opinion in Obstetrics and Gynecology

JF - Current Opinion in Obstetrics and Gynecology

SN - 1040-872X

IS - 5

ER -